The increased incidence and decreased mortality of breast cancer have produced an increased number of breast cancer survivors. The type of sequelae and comorbidities that these patients present call for a collaborative follow-up by hospital-based specialized care and primary care. In this document, we present a guideline drafted and agreed among scientific societies whose members care for breast cancer survivors. The purpose of this guideline is to achieve the shared and coordinated follow-up of these patients by specialized care and primary care professionals. In it, we review the health issues derived from the treatments performed, with recommendations about the therapeutic approach to each of them, as well as a proposal for joint follow-...
Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused ...
Background: To describe the overall and disease-free survival at five and ten years after breast can...
Oncologic follow-up and surveillance after curative therapy for invasive breast cancer serves as a q...
Women who were previously treated for breast cancer (BC) are an important particular subgroup of wom...
Women who were previously treated for breast cancer (BC) are an important particular subgroup of wom...
The development of a recommendation was intended for the follow-up of breast cancer patients treated...
Purpose: To evaluate adherence with follow-up criteria as suggested by the national guideline for br...
A follow-up assessment plan after radical treatment is a part of a comprehensive approach to treatin...
Background: The number of breast cancer (BC) survivors is increasing due to the aging of the populat...
Objective To review evidence-based (EB) recommendations on survivorship care for primary care provid...
Breast cancer survivors may experience long-term treatment complications, must live with the risk of...
Breast cancer survivors may experience long-term treatment complications, must live with the risk of...
AbstractBreast cancer survivors may experience long-term treatment complications, must live with the...
Worldwide, there are over 6 million women with a personal history of breast cancer. Survivors may ex...
Objective: To review evidence-based (EB) recommendations on survivorship care for primary care provi...
Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused ...
Background: To describe the overall and disease-free survival at five and ten years after breast can...
Oncologic follow-up and surveillance after curative therapy for invasive breast cancer serves as a q...
Women who were previously treated for breast cancer (BC) are an important particular subgroup of wom...
Women who were previously treated for breast cancer (BC) are an important particular subgroup of wom...
The development of a recommendation was intended for the follow-up of breast cancer patients treated...
Purpose: To evaluate adherence with follow-up criteria as suggested by the national guideline for br...
A follow-up assessment plan after radical treatment is a part of a comprehensive approach to treatin...
Background: The number of breast cancer (BC) survivors is increasing due to the aging of the populat...
Objective To review evidence-based (EB) recommendations on survivorship care for primary care provid...
Breast cancer survivors may experience long-term treatment complications, must live with the risk of...
Breast cancer survivors may experience long-term treatment complications, must live with the risk of...
AbstractBreast cancer survivors may experience long-term treatment complications, must live with the...
Worldwide, there are over 6 million women with a personal history of breast cancer. Survivors may ex...
Objective: To review evidence-based (EB) recommendations on survivorship care for primary care provi...
Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused ...
Background: To describe the overall and disease-free survival at five and ten years after breast can...
Oncologic follow-up and surveillance after curative therapy for invasive breast cancer serves as a q...